Poliomyelitis
📧 Sign up to get email alerts when something new happens for Poliomyelitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age [Phase 2]
Phase 2 immunogenicity and safety study of GSK's GSK2202083A vaccine in healthy infants aged 2, 3, and 4 months completed.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers [Phase 2]
Phase 2 trial assessing immunogenicity and reactogenicity of a booster dose of GSK2036874A vaccine in healthy toddlers; study completed with…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine [Phase 3]
Phase 3 immunogenicity and safety study of GSK's Infanrix-IPV+Hib vaccine completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib) [Phase 3]
Phase 3 safety study of GSK's DTPa-IPV/Hib vaccine (Infanrix-IPV/Hib) has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. [Phase 2]
Phase 2 feasibility study of GSK's GSK2202083A vaccine in healthy infants at 3, 5, and 11 months was terminated, with results posted in 2017…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine [Phase 3]
A Phase 3 study evaluated the safety of two combination vaccines (DTPa-IPV/Hib and DTPa-HBV-IPV/Hib) in infants who had received hepatitis B…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants [Phase 4]
Phase 4 trial updating safety and reactogenicity of DTPa-IPV/Hib vaccine administered at 3, 4, 5 and 18 months in healthy infants; completed…
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Regulatory Post-Marketing Surveillance Study for TETRAXIM™ [Phase 4]
Phase 4 post-marketing surveillance study for TETRAXIM. The trial completed and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ [Phase 4]
Phase 4 study assessing antibody persistence in children previously vaccinated with Infanrix Hexa or Infanrix-IPV/Hib; completed with result…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated Toddlers [Phase 3]
A Phase 3 trial reports the immunogenicity and safety of a booster dose of Poliorix, an inactivated poliovirus vaccine, in toddlers who have…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants [Phase 4]
Phase 4 trial update on immunogenicity and safety of Infanrix Hexa in infants, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age [Phase 2]
Phase 2 trial update evaluating the immunogenicity and safety of a pentavalent DTPa-HBV-IPV/Hib vaccine given at 2, 3, and 4 months of age.
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Assessment of Community Transmission of Sabin Type 2 Virus in Bangladesh [Phase 3]
A Phase 3 clinical trial in Bangladesh is assessing community transmission and shedding of Sabin type 2 poliovirus after vaccination. The st…
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants [Phase 3]
GlaxoSmithKline completed a Phase 3 trial comparing immunogenicity and safety of two formulations of the DTPa-HBV-IPV/Hib vaccine in healthy…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of GlaxoSmithKline's pentavalent DTPa-HBV-IPV/Hib vaccine in Indian infants across two va…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488 [Phase 2]
Phase 2 clinical trial update evaluating a booster dose of GlaxoSmithKline's 10-valent pneumococcal conjugate vaccine and a single dose of t…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants [Phase 3]
Phase 3 trial evaluating the immunogenicity and reactogenicity of GSK DTPa-HBV-IPV and Hib vaccines when coadministered to healthy infants.
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine [Phase 3]
Phase 3 trial update evaluating the immunogenicity and reactogenicity of the DTPa-HBV-IPV/Hib vaccine given in a schedule with subsequent va…
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course [Phase 4]
Phase 4 trial comparing immunogenicity and reactogenicity of INFANRIX HEXA and INFANRIX HEXAVAC as a primary vaccination course; completed s…
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV) [Phase 2]
Phase 2 clinical trial protocol for an inactivated poliovirus vaccine made from Sabin strains (IPV) has been documented, with the trial stat…
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules [Phase 4]
A Phase 4 clinical trial update assessing the intestinal and humoral immune responses to sequential polio vaccination schedules has been com…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers [Phase 3]
A Phase 3 trial comparing Pediacel to Infanrix-IPV+Hib when co-administered with Prevenar in infants and toddlers has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine [Phase 3]
A Phase 3 randomized trial evaluating the immunogenicity and safety of the bivalent oral poliovirus vaccine (types 1 and 3) has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Polio End-game Strategies - Poliovirus Type 2 Challenge Study [Phase 4]
A Phase 4 poliovirus challenge study investigating end-game strategies for poliomyelitis has completed, per sponsor Aga Khan University.
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination [Phase 3]
Phase 3 trial update reports antibody persistence at ages 3.5 and 4.5 years after primary and booster vaccination with DTaP-IPV-HepB-PRP~T o…